Acceleration of scrapie in mice by target-organ treatment with interferon inducers

Insights

Interferon inducers like poly(I:C), statolon, and Sendai virus were tested for scrapie treatment in mice. Most inducers accelerated disease progression and shortened survival times.

Area of Science:

  • Neuroscience
  • Immunology
  • Virology

Background:

  • Scrapie is a fatal neurodegenerative disease caused by prions.
  • Interferon inducers modulate the immune system and have been explored for antiviral and anticancer properties.

Purpose of the Study:

  • To investigate the effect of interferon inducers on scrapie progression in a mouse model.
  • To determine if intracerebral administration of interferon inducers could alter the course of scrapie disease.

Main Methods:

  • Mice were inoculated intracerebrally with the Chandler strain of scrapie agent.
  • Interferon inducers, including poly(I:C), statolon, and Sendai virus, were administered intracerebrally before and after infection.
  • Survival times and disease progression were monitored using clinical scoring.

Main Results:

  • All treatments, except low-dose poly(I:C), accelerated mortality in scrapie-infected mice.
  • Poly(I:C) (30 µg weekly) shortened mean survival by 13.5 days.
  • Statolon and Sendai virus shortened mean survival by 18.5 and 21.7 days, respectively.
  • Disease acceleration was confirmed by clinical scoring.

Conclusions:

  • Intracerebral administration of interferon inducers can accelerate scrapie disease progression in mice.
  • The findings suggest that modulating the immune response with interferon inducers may exacerbate prion diseases.
  • Further research is needed to understand the mechanisms underlying this acceleration.

Related Concept Videos